Management of hypertension in the elderly

Nature Reviews Cardiology

Volumn 9, Issue 5, 2012, Pages 286-296

  Pimenta, Eduardo ^a   Oparil, Suzanne ^b  

^a UNIVERSITY OF QUEENSLAND   (Australia)

^b University of Alabama at Birmingham   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

AMFEBUTAMONE; AMITRIPTYLINE; AMOXAPINE; ANTIHYPERTENSIVE AGENT; CHLORPROMAZINE; CLOMIPRAMINE; CLONAZEPAM; CLOZAPINE; CYCLOOXYGENASE 2 INHIBITOR; DESIPRAMINE; DEXAMPHETAMINE; DIAZEPAM; DOXEPIN; DULOXETINE; FLUPHENAZINE; IMIPRAMINE; ISOCARBOXAZID; METHYLPHENIDATE; NEFAZODONE; NONSTEROID ANTIINFLAMMATORY AGENT; NORTRIPTYLINE; OLANZAPINE; PHENELZINE; PLACEBO; RISPERIDONE; THIORIDAZINE; TRANYLCYPROMINE; TRAZODONE; UNINDEXED DRUG; VENLAFAXINE;

AGED; ANTIHYPERTENSIVE THERAPY; ARTERIAL STIFFNESS; ARTERY COMPLIANCE; ATHEROSCLEROTIC CARDIOVASCULAR DISEASE; BLOOD PRESSURE; CARDIOVASCULAR RISK; CHRONIC KIDNEY DISEASE; COMORBIDITY; DRUG MEGADOSE; ENDOTHELIAL DYSFUNCTION; FOOD; FOOD DRUG INTERACTION; GROUPS BY AGE; HUMAN; HYPERTENSION; HYPOTENSION; KIDNEY ARTERY STENOSIS; KIDNEY DYSFUNCTION; LIFESTYLE MODIFICATION; MORBIDITY; MORTALITY; ORTHOSTATIC HYPOTENSION; PATHOPHYSIOLOGY; PATIENT ASSESSMENT; POLYPHARMACY; PRACTICE GUIDELINE; PRESSOR RESPONSE; PRIORITY JOURNAL; PULSE WAVE; RANDOMIZED CONTROLLED TRIAL (TOPIC); REVIEW; SIDE EFFECT; SLEEP APNEA SYNDROME; SODIUM RESTRICTION; SYSTOLIC HYPERTENSION;

AGED; ANTIHYPERTENSIVE AGENTS; BLOOD PRESSURE; DISEASE MANAGEMENT; HUMANS; HYPERTENSION; MORBIDITY; RISK FACTORS; WORLD HEALTH;

EID: 84859766854     PISSN: 17595002     EISSN: 17595010     Source Type: Journal    
DOI: 10.1038/nrcardio.2012.27     Document Type: Review

References (108)

1. Kearney, P. M. et al. Global burden of hypertension: analysis of worldwide data. Lancet 365, 217-223 (2005).
2. Roger, V. L. et al. Heart disease and stroke statistics-2012 update: a report from the American Heart Association. Circulation 125, e2-e220 (2012).
3. Lawes, C. M., Vander Hoorn, S. & Rodgers, A. Global burden of blood?pressure?related disease, 2001. Lancet 371, 1513-1518 (2008).
4. Lloyd-Jones, D. M., Evans, J. C. & Levy, D. Hypertension in adults across the age spectrum: current outcomes and control in the community. JAMA 294, 466-472 (2005).
5. The Federal Interagency Forum on Aging-Related Statistics. Older Americans 2010: Key Indicators of Well-Being. AgingStats.gov [online], http://www.agingstats.gov/agingstatsdotnet/Main-Site/Data/2010-Documents/Docs/ OA-2010.pdf (2010).
6. Japanese Ministry of Internal Affairs and Communications, Statistics Bureau, Director-General for Policy Planning (Statistical Standards) & Statistical Research and Training Institute. August 1, 2011 (final estimates) to January 1, 2012 (provisional estimates) population estimates by age (5?year age group) and sex [online], http://www.stat.go.jp/english/data/jinsui/tsuki/index. htm (2012).
7. Statistics Canada. Population projections for Canada, provinces and territories 2009 to 2036 [online], www.statcan.gc.ca/pub/91-520-x/91-520- x2010001-eng.htm (2010).
8. Office for National Statistics. Population; Older people. Regional profiles: population and migration [online], http://ons.gov.uk/ons/taxonomy/ index.html?nscl=Older+People (2011).
9. Christensen, K., Doblhammer, G., Rau, R. & Vaupel, J. W. Ageing populations: the challenges ahead. Lancet 374, 1196-1208 (2009).
10. Ong, K. L., Cheung, B. M., Man, Y. B., Lau, C. P. & Lam, K. S. Prevalence, awareness, treatment, and control of hypertension among United States adults 1999-2004. Hypertension 49, 69-75 (2007).
11. Wolf-Maier, K. et al. Hypertension prevalence and blood pressure level in 6 European countries, Canada and the United States. JAMA 289, 2363-2369 (2003).
12. Pimenta, E. Hypertension in women. Hypertens. Res. 35, 148-152 (2012).
13. Pimenta, E., Calhoun, D. A. & Oparil, S. in Cardiology 3rd edn (eds Crawford, M. H., DiMarco, J. P. & Paulus, W. J.) 511-522 (Elsevier, Philadelphia, 2009).
14. Laurent, S. & Boutouyrie, P. Recent advances in arterial stiffness and wave reflection in human hypertension. Hypertension 49, 1202-1206 (2007).
15. Dao, H. H., Essalihi, R., Bouvet, C. & Moreau, P. Evolution and modulation of age-related medial elastocalcinosis: impact on large artery stiffness and isolated systolic hypertension. Cardiovasc. Res. 66, 307-317 (2005).
16. O'Rourke, M. F. & Hashimoto, J. Mechanical factors in arterial aging: a clinical perspective. J. Am. Coll. Cardiol. 50, 1-13 (2007).
17. Franklin, S. S. et al. Hemodynamic patterns of age-related changes in blood pressure. The Framingham Heart Study. Circulation 96, 308-315 (1997).
18. Pearson, J. D., Morrell, C. H., Brant, L. J., Landis, P. K. & Fleg, J. L. Age-associated changes in blood pressure in a longitudinal study of healthy men and women. J. Gerontol. A. Biol. Sci. Med. Sci. 52, M177-M183 (1997).
19. Bulpitt, C. J. et al. Proportion of patients with isolated systolic hypertension who have burned-out diastolic hypertension. J. Hum. Hypertens. 9, 675-678 (1995).
20. Laurent, S. et al. Expert consensus document on arterial stiffness: methodological issues and clinical applications. Eur. Heart J. 27, 2588-2605 (2006).
21. Wallace, S. M. et al. Isolated systolic hypertension is characterized by increased aortic stiffness and endothelial dysfunction. Hypertension 50, 228-233 (2007).
22. Celermajer, D. S, Sorensen, K. E, Bull, C., Robinson, J. & Deanfield, J. E. Endothelium-dependent dilation in the systemic arteries of asymptomatic subjects relates to coronary risk factors and their interaction. J. Am. Coll. Cardiol. 24, 1468-1474 (1994).
23. Celermajer, D. S. et al. Aging is associated with endothelial dysfunction in healthy men years before the age-related decline in women. J. Am. Coll. Cardiol. 24, 471-476 (1994).
24. Stewart, K. J. et al. Exaggerated exercise blood pressure is related to impaired endothelial vasodilator function. Am. J. Hypertens. 17, 314-320 (2004).
25. Aronow, W. S. et al. ACCF/AHA 2011 expert consensus document on hypertension in the elderly: a report of the American College of Cardiology Foundation Task Force on Clinical Expert Consensus Documents. Circulation 123, 2434-2506 (2011).
26. Pimenta, E, Gaddam, K. K. & Oparil, S. Mechanisms and treatment of resistant hypertension. J. Clin. Hypertens. (Greenwich) 10, 239-244 (2008).
27. Dubovsky, S. L. in Hypertension Primer: The Essentials of High Blood Pressure 4th ed. (eds Izzo, J. L. Jr, Sica, D. A. & Black, H. R.) 545-549 (Lippincott Williams & Wilkins, Philadelphia, 2008).
28. Davies, S. J. et al. Drug intolerance due to nonspecific adverse effects related to psychiatric morbidity in hypertensive patients. Arch. Int. Med. 163, 592-600 (2003).
29. Johannessen, L. et al. Increased risk of hypertension in patients with bipolar disorder and patients with anxiety compared to background populations and patients with schizophrenia. J. Affect. Disord. 95, 13-17 (2006).
30. Kim, M. T. et al. Depression, substance use, adherence behaviors, and blood pressure in urban hypertensive black men. Ann. Behav. Med. 26, 24-31 (2003).
31. Khurana, R. N. & Baudendistel, T. E. Hypertensive crisis associated with venlafaxine. Am. J. Med. 115, 676-677 (2003).
32. Dedier, J. et al. Nonnarcotic analgesic use and the risk of hypertension in US women. Hypertension 40, 604-608 (2002).
33. Aw, T. J., Haas, S. J., Liew, D. & Krum, H. Meta?analysis of cyclooxygenase?2 inhibitors and their effects on blood pressure. Arch. Intern. Med. 165, 490-496 (2005).
34. Somers, V. K. et al. Sleep apnea and cardiovascular disease: an American Heart Association/American College Of Cardiology Foundation Scientific Statement from the American Heart Association Council for High Blood Pressure Research Professional Education Committee, Council on Clinical Cardiology, Stroke Council, and Council On Cardiovascular Nursing. In collaboration with the National Heart, Lung, and Blood Institute National Center on Sleep Disorders Research (National Institutes of Health). Circulation 118, 1080-1111 (2008).
35. Strohl, K. P. & Redline, S. Recognition of obstructive sleep apnea. Am. J. Respir. Crit. Care Med. 154 (2 Pt 1), 279-289 (1996).
36. Kapa, S., Sert Kuniyoshi, F. H. & Somers, V. K. Sleep apnea and hypertension: interactions and implications for management. Hypertension 51, 605-608 (2008).
37. Worsnop, C. J. et al. The prevalence of obstructive sleep apnea in hypertensives. Am. J. Respir. Crit. Care Med. 157, 111-115 (1998).
38. Grote, L. et al. Sleep-related breathing disorder is an independent risk factor for systemic hypertension. Am. J. Respir. Crit. Care Med. 160, 1875-1882 (1999).
39. Peppard, P. E., Young, T., Palta, M. & Skatrud, J. Prospective study of the association between sleep-disordered breathing and hypertension. N. Engl. J. Med. 342, 1378-1384 (2000).
40. Nieto, F. J. et al. Association of sleep-disordered breathing, sleep apnea, and hypertension in a large community-based study. Sleep Heart Health Study. JAMA 283, 1829-1836 (2000).
41. Munoz, R. et al. Severe sleep apnea and risk of ischemic stroke in the elderly. Stroke 37, 2317-2321 (2006).
42. Ancoli-Israel, S. et al. Sleep disordered breathing in community-dwelling elderly. Sleep 14, 486-495 (1991).
43. Bixler, E., Vgontzas, A., Ten Have, T., Tyson, K. & Kales, A. Effects of age on sleep apnea in men: I. Prevalence and severity. Am. J. Respir. Crit. Care. Med. 157, 144-148 (1998).
44. Redline, S. Epidemiology of sleep-disordered breathing. Semin. Respir. Crit. Care. Med. 19, 113-122 (1998).
45. Bixler, E. O. et al. Prevalence of sleep-disordered breathing in women: effects of gender. Am. J. Respir. Crit. Care. Med. 163, 608-613 (2001).
46. Durán, J., Esnaola, S., Rubio, R. & Iztueta, A. Obstructive sleep apnea-hypopnea and related clinical features in a population-based sample of subjects aged 30 to 70 yr. Am. J. Respir. Crit. Care. Med. 163, 685-689 (2001).
47. Young, T., Peppard, P. E. & Gottlieb, D. J. Epidemiology of obstructive sleep apnea: a population health perspective. Am. J. Respir. Crit. Care Med. 165, 1217-1239 (2002).
48. Young, T. et al. Predictors of sleep-disordered breathing in community dwelling adults: the Sleep Heart Health Study. Arch. Intern. Med. 162, 893-900 (2002).
49. Lozano, L. et al. Continuous positive airway pressure treatment in sleep apnea patients with resistant hypertension: a randomized, controlled trial. J. Hypertens. 28, 2161-2168 (2010).
50. Gaddam, K. et al. Spironolactone reduces severity of obstructive sleep apnea in patients with resistant hypertension: a preliminary report. J. Hum. Hypertens. 24, 532-537 (2010).
51. Witkowski, A. et al. Effects of renal sympathetic denervation on blood pressure, sleep apnea course, and glycemic control in patients with resistant hypertension and sleep apnea. Hypertension 58, 559-565 (2011).
52. Baggio, B. et al. Atherosclerotic risk factors and renal function in the elderly: the role of hyperfibrinogenemia and smoking. Results from the Italian Longitudinal Study on Ageing (ILSA). Nephrol. Dial. Transplant. 20, 114-123 (2005).
53. Beck, L. H. The aging kidney. Defending a delicate balance of fluid and electrolytes. Geriatrics 55, 26-28, 31-32 (2000).
54. Levey, A. S. & Coresh, J. Chronic kidney disease. Lancet 379, 165-180 (2012).
55. Ritz, E. Hypertension and kidney disease. Clin. Nephrol. 74, S39-S43 (2010).
56. Young, J. H. et al. Blood pressure and decline in kidney function: findings from the Systolic Hypertension in the Elderly Program (SHEP). J. Am. Soc. Nephrol. 13, 2776-2782 (2002).
57. US National Library of Medicine. ClinicalTrials.gov [online], http://clinicaltrials.gov/ct2/show/NCT01206062 (2010).
58. Schwartz, C. J. & White, T. A. Stenosis of renal artery: an unselected necropsy study. BMJ 2, 1415-1421 (1964).
59. Goldblatt, H., Lynch, J., Hanzal, R. F. & Summerville, W. W. Studies on experimental hypertension: I. The production of persistent elevation of systolic blood pressure by means of renal ischemia. J. Exp. Med. 59, 347-379 (1934).
60. Schachter, M. E. et al. Incidental atherosclerotic renal artery stenosis in patients undergoing elective coronary angiography: are these lesions significant? Am. J. Nephrol. 29, 434-439 (2009).
61. Zalunardo, N. et al. Incidental atherosclerotic renal artery stenosis diagnosed at cardiac catheterization: no difference in kidney function with or without stenting. Am. J. Nephrol. 28, 921-928 (2008).
62. Pearce, J. D. et al. Progression of atherosclerotic renovascular disease: a prospective population-based study. J. Vasc. Surg. 44, 955-962 (2006).
63. Wheatley, K. et al. Revascularization versus medical therapy for renal-artery stenosis. N. Engl. J. Med. 361, 1953-1962 (2009).
64. Cooper, C. J. et al. Stent revascularization for the prevention of cardiovascular and renal events among patients with renal artery stenosis and systolic hypertension: rationale and design of the CORAL trial. Am. Heart J. 152, 59-66 (2006).
65. US National Library of Medicine. ClinicalTrials.gov [online], http://clinicaltrials.gov/ct/show/NCT00081731 (2010).
66. Chrysochou, C., Sinha, S., Chalmers, N., Kalra, P. R. & Kalra, P. A. Anuric acute renal failure and pulmonary edema: a case for urgent action. Int. J. Cardiol. 132, e31-e33 (2009).
67. Pickering, T. G. et al. Recurrent pulmonary edema in hypertension due to bilateral renal artery stenosis: treatment by angioplasty or surgical revascularization. Lancet 2, 551-552 (1988).
68. Chobanian, A. V. et al. Seventh report of the Joint National Committee on Prevention, Detection, Evaluation, and Treatment of High Blood Pressure. Hypertension 42, 1206-1252 (2003).
69. Gregory, S., Bakir, S. & Oparil, S. in Manual of Hypertension. (eds Mancia, G. et al.) 643-671 (Churchill Livingston, New York, 2001).
70. Spence, J D. Pseudo-hypertension in the elderly: still hazy, after all these years. J. Hum. Hypertens. 11, 621-623 (1997).
71. Messerli, F. H., Ventura, H. O. & Amodeo, C. Osler's maneuver and pseudohypertension. N. Engl. J. Med. 312, 1548-1551 (1985).
72. Luciano, G. L., Brennan, M. J. & Rothberg, M. B. Postprandial hypotension. Am. J. Med. 123, 281.e1-281e6 (2010).
73. Vaitkevicius, P. V., Esserwein, D. M., Maynard, A. K., O'Connor, F. C. & Fleg, J. L. Frequency and importance of postprandial blood pressure reduction in elderly nursing-home patients. Ann. Intern. Med. 115, 865-870 (1991).
74. Aronow, W. S. & Ahn, C. Postprandial hypotension in 499 elderly persons in a long-term health care facility. J. Am. Geriatr. Soc. 42, 930-932 (1994).
75. Krause, T., Lovibond, K., Caulfield, M., McCormack, T. & Williams, B. Guideline Development Group. Management of hypertension: summary of NICE guidance. BMJ 343, d4891 (2011).
76. Pickering, T. G. et al. Call to action on use and reimbursement for home blood pressure monitoring: executive summary: a joint scientific statement from the American Heart Association, American Society of Hypertension, and Preventive Cardiovascular Nurses Association. Hypertension 52, 10-29 (2008).
77. Bobrie, G. et al. Cardiovascular prognosis of masked hypertension detected by blood pressure self-measurement in elderly treated hypertensive patients. JAMA 291, 1342-1349 (2004).
78. Fagard, R. H., Van Den Broeke, C. & De Cort, P. Prognostic significance of blood pressure measured in the office, at home and during ambulatory monitoring in older patients in general practice. J. Hum. Hypertens. 19, 801-807 (2005).
79. Beckett, N. S. et al. Treatment of hypertension in patients 80 years of age or older. N. Engl. J. Med. 358, 1887-1898 (2008).
80. Peters, R. et al. Incident dementia and blood pressure lowering in the Hypertension in the Very Elderly Trial cognitive function assessment (HYVET-COG): a double-blind, placebo controlled trial. Lancet Neurol. 7, 683-689 (2008).
81. Beckett, N. et al. Immediate and late benefits of treating very elderly people with hypertension: results from active treatment extension to Hypertension in the Very Elderly randomised controlled trial. BMJ 344, d7541 (2012).
82. Verdecchia, P. et al. Usual versus tight control of systolic blood pressure in non-diabetic patients with hypertension (Cardio-Sis): an open-label randomised trial. Lancet 374, 525-533 (2009).
83. JATOS Study Group. Principal results of the Japanese Trial to Assess Optimal Systolic Blood Pressure in Elderly Hypertensive Patients (JATOS). Hypertens. Res. 31, 2115-2127 (2008).
84. Cushman, W. C. et al. Effects of intensive blood-pressure control in type 2 diabetes mellitus. N. Engl. J. Med. 362, 1575-1585 (2010).
85. Whelton, P. K. et al. Primary prevention of hypertension: clinical and public health advisory from The National High Blood Pressure Education Program. JAMA 288, 1882-1888 (2002).
86. Appel, L. J. et al. Dietary approaches to prevent and treat hypertension: a scientific statement from the American Heart Association. Hypertension 47, 296-308 (2006).
87. Whelton, S. P., Chin, A., Xin, X. & He, J. Effect of aerobic exercise on blood pressure: a meta-analysis of randomized, controlled trials. Ann. Intern. Med. 136, 493-503 (2002).
88. Xin, X. et al. Effects of alcohol reduction on blood pressure: a meta-analysis of randomized controlled trials. Hypertension 38, 1112-1117 (2001).
89. Mackey, R. H. Weighing benefits for older runners. Arch. Intern. Med. 168, 1948-1949 (2008).
90. Fernandez, S., Scales, K. L., Pineiro, J. M., Schoenthaler, A. M. & Ogedegbe, G. A senior center-based pilot trial of the effect of lifestyle intervention on blood pressure in minority elderly people with hypertension. J. Am. Geriatr. Soc. 56, 1860-1866 (2008).
91. Young, D. R., Appel, L. J., Jee, S. & Miller, E. R. 3rd The effects of aerobic exercise and T'ai Chi on blood pressure in older people: results of a randomized trial. J. Am. Geriatr. Soc. 47, 277-284 (1999).
92. Stewart, K. J. et al. Effect of exercise on blood pressure in older persons: a randomized controlled trial. Arch. Intern. Med. 165, 756-762 (2005).
93. Kolbe-Alexander, T. L., Lambert, E. V. & Charlton, K. E. Effectiveness of a community based low intensity exercise program for older adults. J. Nutr. Health Aging 10, 21-29 (2006).
94. Appel, L. J. et al. Effects of reduced sodium intake on hypertension control in older individuals: results from the Trial of Nonpharmacologic Interventions in the Elderly (TONE). Arch. Intern. Med. 161, 685-693 (2001).
95. Xin, X. et al. Effects of alcohol reduction on blood pressure: a meta-analysis of randomized controlled trials. Hypertension 38, 1112-1117 (2001).
96. Mellen, P. B., Palla, S. L., Goff, D. C. Jr & Bonds, D. E. Prevalence of nutrition and exercise counseling for patients with hypertension. United States, 1999 to 2000. J. Gen. Intern. Med. 19, 917-924 (2004).
97. Pahor, M. & Applegate, W. B. Recent advances. Geriatric medicine. BMJ 315, 1071-1074 (1997).
98. Hui, K. K. in Cardiovascular Pharmacology and Therapeutics (eds Singh, B., Dzau, V., Vanhoutte, P. & Woosley, R.) 1130-1142 (Churchill Livingstone, New York, 1994).
99. Frishman, W. Appendices in Cardiovascular Pharmacotherapeutics 2nd edn (eds Frishman, W. H., Sonnenblick, E. & Sica, D. A.) 587-750 (McGraw-Hill, New York, 2004).
100. Turnbull, F. for the Blood Pressure Lowering Treatment Trialists' Collaboration. Effects of different blood-pressure-lowering regimens on major cardiovascular events: results of prospectively-designed overviews of randomised trials. Lancet 362, 1527-1535 (2003).
101. Turnbull, F. et al. Effects of different regimens to lower blood pressure on major cardiovascular events in older and younger adults: meta-analysis of randomised trials. BMJ 336, 1121-1123 (2008).
102. Mancia, G. et al. 2007 Guidelines for the Management of Arterial Hypertension: The Task Force for the Management of Arterial Hypertension of the European Society of Hypertension (ESH) and of the European Society of Cardiology (ESC). J. Hypertens. 25, 1105-1187 (2007).
103. Mancia, G. et al. Reappraisal of European guidelines on hypertension management: a European Society of Hypertension Task Force document. J. Hypertens. 27, 2121-2158 (2009).
104. Messerli, F. H., Grossman, E. & Goldbourt, U. Are β?blockers efficacious as first-line therapy for hypertension in the elderly? A systematic review. JAMA 279, 1903-1907 (1998).
105. Lindholm, L. H., Carlberg, B. & Samuelsson, O. Should β blockers remain first choice in the treatment of primary hypertension? A meta-analysis. Lancet 366, 1545-1553 (2005).
106. Lindholm, L. H., Carlberg, B. & Samuelsson, O. Beta blockers in primary hypertension: do age and type of beta-blocker matter? J. Hypertens. 24, 2143-2145 (2006).
107. Dahlöf, B. et al. Cardiovascular morbidity and mortality in the Losartan Intervention For Endpoint reduction in hypertension study (LIFE): a randomised trial against atenolol. Lancet 359, 995-1003 (2002).
108. Dahlöf, B. et al. Prevention of cardiovascular events with an antihypertensive regimen of amlodipine adding perindopril as required versus atenolol adding bendroflumethiazide as required, in the Anglo-Scandinavian Cardiac Outcomes Trial-Blood Pressure Lowering Arm (ASCOT-BPLA): a multicenter randomised controlled trial. Lancet 366, 895-906 (2005).